Vitamin D metabolism in the premature newborn: A randomized trial

Clinical Nutrition

Volumn 35, Issue 4, 2016, Pages 835-841

  Hanson, Corrine ^a   Jones, Glenville ^b   Lyden, Elizabeth ^a   Kaufmann, Martin ^b   Armas, Laura ^c   Anderson Berry, Ann ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Infant nutrition; Prematurity; Vitamin D; Vitamin D metabolism

Indexed keywords

3 EPI 25 HYDROXYVITAMIN D3; CALCIFEDIOL; COLECALCIFEROL; DRUG METABOLITE; SECALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG METABOLISM; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; BLOOD; CHEMISTRY; COHORT ANALYSIS; DIETARY SUPPLEMENT; DRUG EFFECTS; FETUS BLOOD; INFANT; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; CHOLECALCIFEROL; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; FETAL BLOOD; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; TANDEM MASS SPECTROMETRY; VITAMIN D;

EID: 84971343062     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.07.023     Document Type: Article

References (37)

1. Thorne-Lyman A., Fawzi W.W. Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr Perinat Epidemiol 2012, 26(Suppl. 1):75-90.
2. Theodoratou E., Tzoulaki I., Zgaga L., Ioannidis J.P. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014, 348:g2035.
3. Gallo S., Comeau K., Agellon S., Vanstone C., Sharma A., Jones G., et al. Methodological issues in assessing plasma 25-hydroxyvitamin D concentration in newborn infants. Bone 2014, 61:186-190.
4. Singh R.J., Taylor R.L., Reddy G.S., Grebe S.K. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006, 91(8):3055-3061.
5. Yazdanpanah M., Bailey D., Walsh W., Wan B., Adeli K. Analytical measurement of serum 25-OH-vitamin D(3), 25-OH-vitamin D(2) and their C3-epimers by LC-MS/MS in infant and pediatric specimens. Clin Biochem 2013, 46(13-14):1264-1271.
6. Lensmeyer G., Poquette M., Wiebe D., Binkley N. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metab 2012, 97(1):163-168.
7. Strathmann F.G., Sadilkova K., Laha T.J., LeSourd S.E., Bornhorst J.A., Hoofnagle A.N., et al. 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clin Chim Acta 2012, 413(1-2):203-206.
8. Schleicher R.L., Encisco S.E., Chaudhary-Webb M., Paliakov E., McCoy L.F., Pfeiffer C.M. Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum. Clin Chim Acta 2011, 412(17-18):1594-1599.
9. Karras S.N., Shah I., Petroczi A., Goulis D.G., Bili H., Papadopoulou F., et al. An observational study reveals that neonatal vitamin D is primarily determined by maternal contributions: implications of a new assay on the roles of vitamin D forms. Nutr J 2013, 12:77. 2891-12-77.
10. Kamao M., Tatematsu S., Hatakeyama S., Sakaki T., Sawada N., Inouye K., et al. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation. J Biol Chem 2004, 279(16):15897-15907.
11. Sakaki T., Kagawa N., Yamamoto K., Inouye K. Metabolism of vitamin D3 by cytochromes P450. Front Biosci 2005, 10:119-134.
12. Schlingmann K.P., Kaufmann M., Weber S., Irwin A., Goos C., John U., et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011, 365(5):410-421.
13. Dinour D., Beckerman P., Ganon L., Tordjman K., Eisenstein Z., Holtzman E.J. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis. J Urol 2013, 190(2):552-557.
14. Nesterova G., Malicdan M.C., Yasuda K., Sakaki T., Vilboux T., Ciccone C., et al. 1,25-(OH)2D-24 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis. Clin J Am Soc Nephrol 2013, 8(4):649-657.
15. Seo E.G., Norman A.W. Three-fold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24,25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture. J Bone Min Res 1997, 12(4):598-606.
16. Hurst-Kennedy J., Zhong M., Gupta V., Boyan B.D., Schwartz Z. 24R,25-dihydroxyvitamin D3, lysophosphatidic acid, and p53: a signaling axis in the inhibition of phosphate-induced chondrocyte apoptosis. J Steroid Biochem Mol Biol 2010, 122(4):264-271.
17. St-Arnaud R., Naja R.P. Vitamin D metabolism, cartilage and bone fracture repair. Mol Cell Endocrinol 2011, 347(1-2):48-54.
18. St-Arnaud R. CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J Steroid Biochem Mol Biol 2010, 121(1-2):254-256.
19. Hanson C., Armas L., Lyden E., Anderson-Berry A. Vitamin D status and associations in newborn formula-fed infants during initial hospitalization. J Am Diet Assoc 2011, 111(12):1836-1843.
20. Kaufmann M., Gallagher C., Peacock M., Schlingmann K.P., Konrad M., DeLuca H.F., et al. Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D & 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab 2014, 99:2567-2574.
21. Fenton T.R. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003, 3:13.
22. Fenton T.R., Kim J.H. A systematic review and meta-analysis to revise the fenton growth chart for preterm infants. BMC Pediatr 2013, 13:59. 2431-13-59.
23. Astecker N., Reddy G.S., Herzig G., Vorisek G., Schuster I. 1alpha,25-dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1alpha,25-dihydroxyvitamin D3: its production and metabolism in primary human keratinocytes. Mol Cell Endocrinol 2000, 170(1-2):91-101.
24. Rhieu S.Y., Annalora A.J., Wang G., Flarakos C.C., Gathungu R.M., Vouros P., et al. Metabolic stability of 3-epi-1alpha,25-dihydroxyvitamin D3 over 1 alpha 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1. J Cell Biochem 2013, 114(10):2293-2305.
25. Kamao M., Tatematsu S., Sawada N., Sakaki T., Hatakeyama S., Kubodera N., et al. Cell specificity and properties of the C-3 epimerization of vitamin D3 metabolites. J Steroid Biochem Mol Biol 2004, 89-90(1-5):39-42.
26. Bailey D., Veljkovic K., Yazdanpanah M., Adeli K. Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin Biochem 2013, 46(3):190-196.
27. Molnar F., Sigueiro R., Sato Y., Araujo C., Schuster I., Antony P., et al. 1alpha,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. PLoS One 2011, 6(3):e18124.
28. Brown A.J., Ritter C., Slatopolsky E., Muralidharan K.R., Okamura W.H., Reddy G.S. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. J Cell Biochem 1999, 73(1):106-113.
29. Bailey D., Perumal N., Yazdanpanah M., Al Mahmud A., Baqui A.H., Adeli K., et al. Maternal-fetal-infant dynamics of the C3-epimer of 25-hydroxyvitamin D. Clin Biochem 2014, 47(9):816-822.
30. Wagner D., Hanwell H.E., Schnabl K., Yazdanpanah M., Kimball S., Fu L., et al. The ratio of serum 24,25-dihydroxyvitamin D(3) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementation. J Steroid Biochem Mol Biol 2011, 126(3-5):72-77.
31. Taylor A.F., Norman M.E. Vitamin D metabolite levels in normal children. Pediatr Res 1984, 18(9):886-890.
32. Markestad T., Aksnes L., Finne P.H., Aarskog D. Plasma concentrations of vitamin D metabolites in premature infants. Pediatr Res 1984, 18(3):269-272.
33. Folkerth R., Haynes R., Borenstein N., Belliveau R.A., Trachtenberg F., Rosenberg P.A., et al. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol 2004, 63:990-999.
34. Novakovic B., Sibson M., Ng H.K., Manuelpillai U., Rakyan V., Down T., et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene. Implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009, 284(22):14838-14848.
35. Aksnes L., Aarskog D. Plasma concentrations of vitamin D metabolites in puberty: effect of sexual maturation and implications for growth. J Clin Endocrinol Metab 1982, 55(1):94-101.
36. Reiter E.O., Braunstein G.D., Vargas A., Root A.W. Changes in 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D during pregnancy. Am J Obstet Gynecol 1979, 135(2):227-229.
37. Zhou Y., Liang Z., Guo Y., Zhang H.T., Wang K.H. High glucose upregulates CYP24A1 expression which attenuates the abiltiy of 1,25(OH)2D3 to increase NGF secretion in rat Schwan cell line RSC96. Mol Cell Endocrinol 2015, 404:75-81.